[HTML][HTML] Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American …
NI Lindeman, PT Cagle, MB Beasley, DA Chitale… - Journal of Thoracic …, 2013 - Elsevier
Objective To establish evidence-based recommendations for the molecular analysis of lung
cancers that are that are required to guide EGFR-and ALK-directed therapies, addressing …
cancers that are that are required to guide EGFR-and ALK-directed therapies, addressing …
[引用][C] 1. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American …
NI Lindeman - spandidos-publications.com
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK Tyrosine Kinase Inhibitors: guideline from the College Of American Pathologists …
NI Lindeman, PT Cagle, MB Beasley… - Archives of Pathology …, 2013 - go.gale.com
* Objective.--To establish evidence-based recommendations for the molecular analysis of
lung cancers that are required to guide EGFR-and ALK-directed therapies, addressing …
lung cancers that are required to guide EGFR-and ALK-directed therapies, addressing …
[PDF][PDF] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
NI Lindeman, PT Cagle, MB Beasley… - The Journal of …, 2013 - researchgate.net
Objective: To establish evidence-based recommendations for the molecular analysis of lung
cancers that are required to guide EGFR-and ALK-directed therapies, addressing which …
cancers that are required to guide EGFR-and ALK-directed therapies, addressing which …
[PDF][PDF] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
NI Lindeman, PT Cagle, MB Beasley, DA Chitale… - 2013 - img.medsci.cn
Objective.—To establish evidence-based recommendations for the molecular analysis of
lung cancers that are required to guide EGFR-and ALK-directed therapies, addressing …
lung cancers that are required to guide EGFR-and ALK-directed therapies, addressing …
[PDF][PDF] Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
NI Lindeman, PT Cagle, MB Beasley… - Arch Pathol Lab …, 2013 - wwdiagnostics.co.za
Objective.—To establish evidence-based recommendations for the molecular analysis of
lung cancers that are required to guide EGFR-and ALK-directed therapies, addressing …
lung cancers that are required to guide EGFR-and ALK-directed therapies, addressing …
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists …
NI Lindeman, PT Cagle, MB Beasley… - … of Pathology & …, 2013 - search.proquest.com
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine
Kinase Inhibitors Page 1 Special Article Molecular Testing Guideline for Selection of Lung …
Kinase Inhibitors Page 1 Special Article Molecular Testing Guideline for Selection of Lung …
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists …
NI Lindeman, PT Cagle, MB Beasley… - … of pathology & …, 2013 - pubmed.ncbi.nlm.nih.gov
Objective To establish evidence-based recommendations for the molecular analysis of lung
cancers that are required to guide EGFR-and ALK-directed therapies, addressing which …
cancers that are required to guide EGFR-and ALK-directed therapies, addressing which …
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors.
NI Lindeman, PT Cagle, MB Beasley… - … of Pathology & …, 2013 - search.ebscohost.com
Objective.-To establish evidence-based recommendations for the molecular analysis of lung
cancers that are required to guide EGFR-and ALK-directed therapies, addressing which …
cancers that are required to guide EGFR-and ALK-directed therapies, addressing which …
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
NI Lindeman, PT Cagle, MB Beasley… - The Journal of Molecular …, 2013 - infona.pl
Objective: To establish evidence-based recommendations for the molecular analysis of lung
cancers that are required to guide EGFR-and ALK-directed therapies, addressing which …
cancers that are required to guide EGFR-and ALK-directed therapies, addressing which …